New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2013
08:23 EDTCYBXCyberonics upgraded to Buy from Neutral at Lazard Capital
Lazard Capital upgraded Cyberonics following physician checks that indicate inappropriate sales tactics are not widespread following a "whistle-blower" case. Additionally, the firm views valuation as attractive, raised estimates, and believes there is potential for depression reimbursement this year. Price target is $57.
News For CYBX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
06:59 EDTCYBXTulane University to hold a conference
Subscribe for More Information
April 14, 2015
11:31 EDTCYBXSorin-Cyberonics merger receives US antitrust approval
Sorin S.p.A. and Cyberonics announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, relating to their pending merger, has expired, thereby satisfying one of the conditions required to finalize the merger transaction. As previously announced, Sorin and Cyberonics entered into a merger agreement pursuant to which the two companies will combine in an all-stock transaction. The proposed combination of Sorin and Cyberonics will create a new premier global medical technology company. The transaction, unanimously approved by the boards of directors of both companies, is currently expected to be completed by the end of the third calendar quarter of 2015. The transaction is subject to approval by both Sorin and Cyberonics shareholders, the receipt of required regulatory clearances, and other customary closing conditions.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use